According to GlobalData’s medical device pipeline database, nine Dura Substitutes devices are in various stages of development globally. GlobalData’s report Dura Substitutes provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, five are in active development, while the remaining four are in an inactive stage of development. There are two products in the early stages of development, and the remaining three are in the late stages of development.
Neurology devices are designed to diagnose, treat, and monitor conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. Dura substitutes, neuroendoscopes and neurosurgical drills are tracked under this category. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. Biological dura substitutes and synthetic dura substitutes are tracked under this segment. Biological Dura Substitutes are made by bio engineering of tissues from different animals such as cow (bovine pericardium) and pig (porcine intestinal sub mucosal layer). Synthetic Dura Substitutes are made from polymer materials such as Polytetrafluoroethylene (PTFE) and have high tensile strength.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Dura Substitutes pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Dura Substitutes devices. Overall, most of these Dura Substitutes pipeline devices are being developed by private entities.
Key players involved in the active development of Dura Substitutes include Integra LifeSciences, InVivo Therapeutics, Kerecis ehf, Kuros Biosciences, LeMaitre Vascular, Medtronic, Nanonerve, Nurami Medical and Sree Chitra Tirunal Institute for Medical Sciences & Technology.
For a complete picture of the developmental pipeline for Dura Substitutes devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
